Dr. Michel Torbey, MD
Claim this profileThe University of New Mexico - School of Medicine
Studies Stroke
Studies Ischemic Injury
3 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Michel Torbey, MD is currently running
CPAP
for Sleep Apnea After Stroke
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
Recruiting1 award N/A1 criteria
Tissue Kallikrein
for Ischemic Stroke
This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limited treatment options. Participants who have or will receive mechanical thrombectomy (MT) are not eligible for participation. Additionally, participants who have received fibrinolytics are excluded unless they experience a persistent neurological deficit of moderate severity six or more hours after fibrinolytic treatment. Participants considered for this trial should not be denied the use of standard of care (SoC) AIS therapies, such as fibrinolytics or MT, when appropriate. The double-blinded study will be randomized and placebo-controlled at up to approximately 100 sites.
Recruiting0 awards Phase 2 & 37 criteria
More about Michel Torbey, MD
Clinical Trial Related15 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michel Torbey, MD has experience with
- Recombinant Human Tissue Kallikrein
- CPAP
Breakdown of trials Michel Torbey, MD has run
Ischemic Injury
Cerebral Cavernous Malformations
Sleep Apnea
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michel Torbey, MD specialize in?
Michel Torbey, MD focuses on Stroke and Ischemic Injury. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Michel Torbey, MD currently recruiting for clinical trials?
Yes, Michel Torbey, MD is currently recruiting for 2 clinical trials in Albuquerque New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Michel Torbey, MD has studied deeply?
Yes, Michel Torbey, MD has studied treatments such as Recombinant human tissue kallikrein, CPAP.
What is the best way to schedule an appointment with Michel Torbey, MD?
Apply for one of the trials that Michel Torbey, MD is conducting.
What is the office address of Michel Torbey, MD?
The office of Michel Torbey, MD is located at: The University of New Mexico - School of Medicine, Albuquerque, New Mexico 87131 United States. This is the address for their practice at the The University of New Mexico - School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.